Critical illness polyneuropathy and myopathy in the intensive care unit

Nature Reviews Neurology

Volumn 5, Issue 7, 2009, Pages 372-379

  Zink, Wolfgang ^a   Kollmar, Rainer ^b   Schwab, Stefan ^b  

^a UNIVERSITY OF REGENSBURG   (Germany)

^b UNIVERSITY HOSPITAL ERLANGEN   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIOXIDANT; CORTICOSTEROID; GAMMA INTERFERON; INTERLEUKIN 1; INTERLEUKIN 6; MYOD1 PROTEIN; TUMOR NECROSIS FACTOR;

ADULT RESPIRATORY DISTRESS SYNDROME; APOPTOSIS; ARTIFICIAL VENTILATION; CLINICAL FEATURE; CRITICAL ILLNESS; ELECTROMYOGRAPHY; ELECTROPHYSIOLOGY; GENETIC ASSOCIATION; HUMAN; INCIDENCE; INTENSIVE CARE UNIT; MOTOR NERVE CONDUCTION; MOTOR UNIT POTENTIAL; MUSCLE ACTION POTENTIAL; MYOPATHY; OUTCOME ASSESSMENT; PATHOGENESIS; PATHOPHYSIOLOGY; POLYNEUROPATHY; PRIORITY JOURNAL; PROTEIN DEGRADATION; REVIEW; SENSORY NERVE CONDUCTION; METHODOLOGY; MUSCLE DISEASE;

HUMANS; INTENSIVE CARE UNITS; MUSCULAR DISEASES; POLYNEUROPATHIES; RESPIRATION, ARTIFICIAL;

EID: 77949320372     PISSN: 17594758     EISSN: 17594766     Source Type: Journal    
DOI: 10.1038/nrneurol.2009.75     Document Type: Review

References (100)

1. Latronico, N., Guarneri, B. Critical illness myopathy and neuropathy. Minerva Anestesiol. 74, 319-323 (2008).
2. Osler, w. The Principles and Practice of Medicine, 1st edn (D. Appleton, New York, 1892).
3. Mertens, H. G. Disseminated neuropathy following coma. On the differentation of so- called toxic neuropathy [German]. Nervenarzt 32, 71-79 (1961).
4. Bolton, C. F., Gilbert, J. J., Hahn, A. F., Sibbald, W. J. Polyneuropathy in critically ill patients. J. Neurol. Neurosurg. Psychiatry 47, 1223-1231 (1984).
5. Bolton, C. F. et al. Critically ill polyneuropathy: electrophysiological studies and differentiation from Guillain-Barre syndrome. J. Neurol. Neurosurg. Psychiatry 49, 563-573 (1986).
6. Bolton, C. F. Sepsis and the systemic inflammatory response syndrome: neuromuscular manifestations. Crit. Care Med. 24, 1408-1416 (1996).
7. Bolton, C. F. Neuromuscular manifestations of critical illness. Muscle Nerve 32, 140-163 (2005).
8. Lacomis, D., Giuliani, M. J., Van Cott, A. Kramer, D. J. Acute myopathy of intensive care: clinical, electromyographic, and pathological aspects. Ann. Neurol. 40, 645-654 (1996).
9. Latronico, N. et al. Critical illness myopathy and neuropathy. Lancet 347, 1579-1582 (1996).
10. Friedrich, O. Critical illness myopathy: sepsis- mediated failure of the peripheral nervous system. Eur. J. Anaesthesiol. Suppl. 42, 73-82 (2008).
11. Stevens, R. D. et al. Neuromuscular dysfunction acquired in critical illness: a systematic review. Intensive Care Med. 33, 1876-1891 (2007).
12. Hermans, G., De Jonghe, B., Bruyninckx, F, Van den Berghe, G. Clinical review: critical illness polyneuropathy and myopathy. Crit. Care 12, 238 (2008).
13. Guarneri, B., Bertolini, G., Latronico, N. Long- term outcome in patients with critical illness myopathy or neuropathy: the italian multicentre CRiMYNE study. J. Neurol. Neurosurg. Psychiatry 79, 838-841 (2008).
14. De Jonghe, B. et al. Paresis acquired in the intensive care unit: a prospective multicenter study. JAMA 288, 2859-2867 (2002).
15. Ali, N. A. et al. Acquired weakness, handgrip strength, and mortality in critically ill patients. Am. J. Respir. Crit. Care Med. 178, 261-268 (2008).
16. Bednarik, J., Lukas, Z., Vondracek, P. Critical illness polyneuromyopathy: the electrophysiological components of a complex entity. Intensive Care Med. 29, 1505-1514 (2003).
17. Khan, J., Harrison, T. B., Rich, M. M., Moss, M. Early development of critical illness myopathy and neuropathy in patients with severe sepsis. Neurology 67, 1421-1425 (2006).
18. De Letter, M. A. et al. Critical illness polyneuropathy and myopathy (CiPNM): evidence for local immune activation by cytokine- expression in the muscle tissue. J. Neuroimmunol. 106, 206-213 (2000).
19. Witt, N. J. et al. Peripheral nerve function in sepsis and multiple organ failure. Chest 99, 176-184 (1991).
20. Hund, E. Neurological complications of sepsis: critical illness polyneuropathy and myopathy. J. Neurol. 248, 929-934 (2001).
21. Tennila, A. et al. Early signs of critical illness polyneuropathy in iCU patients with systemic inflammatory response syndrome or sepsis. Intensive Care Med. 26, 1360-1363 (2000).
22. Bercker, S. et al. Critical illness polyneuropathy and myopathy in patients with acute respiratory distress syndrome. Crit. Care Med. 33, 711-715 (2005).
23. Steinberg, K. I? et al. Efficacy and safety of corticosteroids for persistent acute respiratory distress syndrome. N. Engl. J. Med. 354, 1671-1684 (2006).
24. de Letter, M. A. et al. Risk factors for the development of polyneuropathy and myopathy in critically ill patients. Crit. Care Med. 29, 2281-2286 (2001).
25. De Jonghe, B., Bastuji-Garin, S., Sharshar, T., Outin, H., Brochard, L. Does iCU-acquired paresis lengthen weaning from mechanical ventilation? Intensive Care Med. 30, 1117-1121 (2004).
26. Leijten, F. S. et al. Critical illness polyneuropathy in multiple organ dysfunction syndrome and weaning from the ventilator. Intensive Care Med. 22, 856-861 (1996).
27. Garnacho-Montero, J., Amaya-Villar, R., Garcia-Garmendia, J. L., Madrazo-Osuna, J., Ortiz-Leyba, C. Effect of critical illness polyneuropathy on the withdrawal from mechanical ventilation and the length of stay in septic patients. Crit. Care Med. 33, 349-354 (2005).
28. Leijten, F. S., Harinck-de Weerd, J. E., Poortvliet, D. C., de Weerd, A. W. The role of polyneuropathy in motor convalescence after prolonged mechanical ventilation. JAMA 274, 1221-1225 (1995).
29. Van den Berghe, G., Schoonheydt, K., Becx, P., Bruyninckx, F., Wouters, P. J. insulin therapy protects the central and peripheral nervous system of intensive care patients. Neurology 64, 1348-1353 (2005).
30. Hermans, G. et al. Benefits of intensive insulin therapy on neuromuscular complications in routine daily critical care practice: a retrospective study. Crit. Care 13, R5 (2009).
31. Hermans, G. et al. impact of intensive insulin therapy on neuromuscular complications and ventilator dependency in the medical intensive care unit. Am. J. Respir. Crit. Care Med. 175, 480-489 (2007).
32. Schweickert, W. D., Hall, J. iCU-acquired weakness. Chest 131, 1541-1549 (2007).
33. Lacomis, D., Campellone, J. V. Critical illness neuromyopathies. Adv. Neurol. 88, 325-335 (2002).
34. Hermans, G., De Jonghe, B., Bruyninckx, F Van den Berghe, G. interventions for preventing critical illness polyneuropathy and critical illness myopathy. Cochrane Database of Systematic Reviews, issue 1. Art. No.: CD006832. doi:10.1002/14651858.CD006832.pub2 (2009).
35. De Jonghe, B. et al. Respiratory weakness is associated with limb weakness and delayed weaning in critical illness. Crit. Care Med. 35, 2007-2015 (2007).
36. Zochodne, D. W. et al. Critical illness polyneuropathy. A complication of sepsis and multiple organ failure. Brain 110, 819-841 (1987).
37. Burnham, E. L., Moss, M., Ziegler, T. R. Myopathies in critical illness: characterization and nutritional aspects. J. Nutr. 135, S1818-S1823 (2005).
38. Eikermann, M. et al. Muscle force and fatigue in patients with sepsis and multiorgan failure. Intensive Care Med. 32, 251-259 (2006).
39. Zifko, U. A., Zipko, H. T., Bolton, C. F. Clinical and electrophysiological findings in critical illness polyneuropathy. J. Neurol. Sci. 159, 186-193 (1998).
40. Bird, S. J. Diagnosis and management of critical illness polyneuropathy and critical illness myopathy. Curr. Treat. Options Neurol. 9, 85-92 (2007).
41. van Mook, W. N., Hulsewe-Evers, R. P. Critical illness polyneuropathy. Curr. Opin. Crit. Care 8, 302-310 (2002).
42. Maramattom, B. V., Wijdicks, E. F. Acute neuromuscular weakness in the intensive care unit. Crit. Care Med. 34, 2835-2841 (2006).
43. Dhand, U. K. Clinical approach to the weak patient in the intensive care unit. Respir. Care 51, 1024-1040 (2006).
44. Schwarz, J., Planck, J., Briegel, J., Straube, A. Single-fiber electromyography, nerve conduction studies, and conventional electromyography in patients with critical-illness polyneuropathy: evidence for a lesion of terminal motor axons. Muscle Nerve 20, 696-701 (1997).
45. Gorson, K. C. Approach to neuromuscular disorders in the intensive care unit. Neurocrit. Care 3, 195-212 (2005).
46. Latronico, N. Neuromuscular alterations in the critically ill patient: critical illness myopathy, critical illness neuropathy, or both? Intensive Care Med. 29, 1411-1413 (2003).
47. De Jonghe, B., Lacherade, J. C., Durand, M. C., Sharshar, T. Critical illness neuromuscular syndromes. Crit. Care Clin. 22, 805-818 (2006).
48. Botteri, M., Guarneri, B. Electrophysiological tests in intensive care. Eur. J. Anaesthesiol. Suppl. 42, 174-180 (2008).
49. Latronico, N. et al. Simplified electrophysiological evaluation of peripheral nerves in critically ill patients: the italian multicentre CRiMYNE study. Crit. Care 11, R11 (2007).
50. Z'Graggen,W. J., Lin, C. S., Howard, R. S., Beale, R. J., Bostock, H. Nerve excitability changes in critical illness polyneuropathy. Brain 129, 2461-2470 (2006).
51. Z'Graggen, W. J., Bostock, H. Nerve membrane excitability testing. Eur. J. Anaesthesiol. Suppl. 42, 68-72 (2008).
52. Seghelini, E. Direct stimulation: a useful technique. Eur. J. Anaesthesiol. Suppl. 42, 181-185 (2008).
53. Rich, M. M., Bird, S. J., Raps, E. C., McCluskey, L. F., Teener, J. W. Direct muscle stimulation in acute quadriplegic myopathy. Muscle Nerve 20, 665-673 (1997).
54. Rich, M. M., Raps, E. C., Bird, S. J. Distinction between acute myopathy syndrome and critical illness polyneuropathy. Mayo Clin. Proc. 70, 198-200 (1995).
55. Trojaborg, W., Weimer, L. H., Hays, A. P. Electrophysiologic studies in critical illness associated weakness: myopathy or neuropathy-a reappraisal. Clin. Neurophysiol. 112, 1586-1593 (2001).
56. Trojaborg, W. Electrophysiologic techniques in critical illness-associated weakness. J. Neurol. Sci. 242, 83-85 (2006).
57. Lefaucheur, J. P., Nordine, T., Rodriguez, P., Brochard, L. Origin of iCU acquired paresis determined by direct muscle stimulation. J. Neurol. Neurosurg. Psychiatry 77, 500-506 (2006).
58. Danon, M. J., Carpenter, S. Myopathy with thick filament (myosin) loss following prolonged paralysis with vecuronium during steroid treatment. Muscle Nerve 14, 1131-1139 (1991).
59. Hasselgren, P. O., Fischer, J. E. Sepsis: stimulation of energy-dependent protein breakdown resulting in protein loss in skelet al. muscle. World J. Surg. 22, 203-208 (1998).
60. Norman, H. et al. A porcine model of acute quadriplegic myopathy: a feasibility study. Acta Anaesthesiol. Scand. 50, 1058-1067 (2006).
61. Hund, E. Myopathy in critically ill patients. Crit. Care Med. 27, 2544-2547 (1999).
62. Latronico, N., Peli, E., Botteri, M. Critical illness myopathy and neuropathy. Curr. Opin. Crit. Care 11, 126-132 (2005).
63. Leung, T. W. et al. Myopathic changes associated with severe acute respiratory syndrome: a postmortem case series. Arch. Neurol. 62, 1113-1117 (2005).
64. Fenzi, F., Latronico, N., Refatti, N., Rizzuto, N. Enhanced expression of E-selectin on the vascular endothelium of peripheral nerve in critically ill patients with neuromuscular disorders. Acta Neuropathol. 106, 75-82 (2003).
65. Young, G. B. Critical illness myopathy: deeper insights. Crit. Care Med. 36, 1977 (2008).
66. Nanas, S. et al. Predisposing factors for critical illness polyneuromyopathy in a multidisciplinary intensive care unit. Acta Neurol. Scand. 118, 175-181 (2008).
67. Bednarik, J., Vondracek, P., Dusek, L., Moravcova, E., Cundrle, i. Risk factors for critical illness polyneuromyopathy. J. Neurol. 252, 343-351 (2005).
68. Visser, L. H. Critical illness polyneuropathy and myopathy: clinical features, risk factors and prognosis. Eur. J. Neurol. 13, 1203-1212 (2006).
69. Hough, C. L., Needham, D. M. The role of future longitudinal studies in iCU survivors: understanding determinants and pathophysiology of weakness and neuromuscular dysfunction. Curr. Opin. Crit. Care 13, 489-496 (2007).
70. Garnacho-Montero, J. et al. Critical illness polyneuropathy: risk factors and clinical consequences. A cohort study in septic patients. Intensive Care Med. 27, 1288-1296 (2001).
71. Van den Berghe, G. insulin therapy for the critically ill patient. Clin. Cornerstone 5, 56-63 (2003).
72. Herridge, M. S. et al. One-year outcomes in survivors of the acute respiratory distress syndrome. N. Engl. J. Med. 348, 683-693 (2003).
73. Friedrich, O. Critical illness myopathy: what is happening? Curr. Opin. Clin. Nutr. Metab. Care 9, 403-409 (2006).
74. Khan, J., Harrison, T. B., Rich, M. M. Mechanisms of neuromuscular dysfunction in critical illness. Crit. Care Clin. 24, 165-177 (2008).
75. Friedrich, O., Fink, R. H., Hund, E. Understanding critical illness myopathy: approaching the pathomechanism. J. Nutr. 135, S1813-S1817 (2005).
76. Showalter, C. J., Engel, A. G. Acute quadriplegic myopathy: analysis of myosin isoforms and evidence for calpain-mediated proteolysis. Muscle Nerve 20, 316-322 (1997).
77. Tiao, G. et al. Sepsis is associated with increased mRNAs of the ubiquitin-proteasome proteolytic pathway in human skelet al. muscle. J. Clin. Invest. 99, 163-168 (1997).
78. Klaude, M. et al. Proteasome proteolytic activity in skelet al. muscle is increased in patients with sepsis. Clin. Sci. (Lond.) 112, 499-506 (2007).
79. Di Giovanni, S., Mirabella, M., D'Amico, A., Tonali, P., Servidei, S. Apoptotic features accompany acute quadriplegic myopathy. Neurology 55, 854-858 (2000).
80. Solomon, V., Goldberg, A. L. importance of the ATP-ubiquitin-proteasome pathway in the degradation of soluble and myofibrillar proteins in rabbit muscle extracts. J. Biol. Chem. 271, 26690-26697 (1996).
81. Solomon, V., Lecker, S. H., Goldberg, A. L. The N-end rule pathway catalyzes a major fraction of the protein degradation in skelet al. muscle. J. Biol. Chem. 273, 25216-25222 (1998).
82. Williams, A. B. et al. Sepsis stimulates release of myofilaments in skelet al. muscle by a calcium- dependent mechanism. FASEB J. 13, 1435-1443 (1999).
83. Acharyya, S. et al. Cancer cachexia is regulated by selective targeting of skelet al. muscle gene products. J. Clin. Invest. 114, 370-378 (2004).
84. Rich, M. M., Pinter, M. J. Sodium channel inactivation in an animal model of acute quadriplegic myopathy. Ann. Neurol. 50, 26-33 (2001).
85. Rich, M. M., Pinter, M. J. Crucial role of sodium channel fast inactivation in muscle fibre inexcitability in a rat model of critical illness myopathy. J. Physiol. 547, 555-566
86. Rich, M. M., Teener, J. W., Raps, E. C., Schotland, D. L., Bird, S. J. Muscle is electrically inexcitable in acute quadriplegic myopathy. Neurology 46, 731-736 (1996).
87. Rich, M. M., Teener, J. W., Raps, E. C. & Bird, S. J. Muscle inexcitability in patients with reversible paralysis following steroids and neuromuscular blockade. Muscle Nerve 21, 1231-1232 (1998).
88. Capasso, M. et al. Possible role for nitric oxide dysregulation in critical illness myopathy. Muscle Nerve 37, 196-202 (2008).
89. Zink, W. et al. Alterations in intracellular Ca2+-homeostasis of skelet al. muscle fibers during sepsis. Crit. Care Med. 36, 1559-1563 (2008).
90. Friedrich, O., Hund, E., Weber, C., Hacke, W., Fink, R. H. Critical illness myopathy serum fractions affect membrane excitability and intracellular calcium release in mammalian skelet al. muscle. J. Neurol. 251, 53-65 2004
91. Van den Berghe, G. et al. intensive insulin therapy in mixed medical/surgical intensive care units: benefit versus harm. Diabetes 55, 3151-3159 (2006).
92. Van den Berghe, G. et al. Outcome benefit of intensive insulin therapy in the critically ill: insulin dose versus glycemic control. Crit. Care Med. 31, 359-366 (2003).
93. Lydon, A., Martyn, J. A. Apoptosis in critical illness. Int.Anesthesiol. Clin. 41, 65-77 (2003).
94. Hough, C., Steinberg, K. P., Taylor Thompson, B., Rubenfeld, G. D., Hudson, L. D. intensive care unit-acquired neuromyopathy and corticosteroids in survivors of persistent ARDS. Intensive Care Med. 35, 63-68 (2009).
95. Teener, J. W., Rich, M. M. Dysregulation of sodium channel gating in critical illness myopathy. J. Muscle Res. Cell Motil. 27, 291-296 (2006).
96. Morris, P. E. et al. Early intensive care unit mobility therapy in the treatment of acute respiratory failure. Crit. Care Med. 36, 2238-2243 (2008).
97. Needham, D. M. Mobilizing patients in the intensive care unit: improving neuromuscular weakness and physical function. JAMA 300, 1685-1690 (2008).
98. de Seze, M. et al. Critical illness polyneuropathy. A 2-year follow-up study in 19 severe cases. Eur. Neurol. 43, 61-69 (2000).
99. Latronico, N., Shehu, i., Seghelini, E. Neuromuscular sequelae of critical illness. Curr. Opin. Crit. Care 11, 381-390 (2005).
100. Kerbaul, F. et al. Combination of histopathological and electromyographic patterns can help to evaluate functional outcome of critical ill patients with neuromuscular weakness syndromes. Crit. Care 8, R358-R366 (2004).